Skip to main content

Table 2 Evolution of the clinical characteristics and illness severity scores of patients according to lactate level (≤ 2 or > 2 mmol/L) and normoxia or hyperoxia treatment

From: Hyperoxia toxicity in septic shock patients according to the Sepsis-3 criteria: a post hoc analysis of the HYPER2S trial

 

Lactate ≤ 2 mmol/L (n = 167)

Lactate > 2 mmol/L (n = 230)

Normoxia (n = 75)

Hyperoxia (n = 92)

p value

Normoxia (n = 122)

Hyperoxia (n =T108)

p value

Mortality at d28

17 (22.7%)

23 (25.0%)

0.680¥

54 (44.3%)

62 (57.4%)

0.054¥

Mortality at d90¥

21 (28.0%)

30 (32.6%)

0.513¥

63 (51.6%)

64 (59.3%)

0.171¥

RRT

14 (18.9%)

25 (27.8%)

0.185

50 (42.7%)

44 (41.5%)

0.853

Days without vasopressor, mean (SD)

21 (10)

19 (9)

0.323

14 (12)

12 (12)

0.149

Days without mechanical ventilation, mean (SD)

16 (9)

13 (10)

0.04

11 (11)

9 (11)

0.131

Days without RRT, mean (SD)

24 (9)

22 (10)

0.12

16 (12)

13 (12)

0.139

Survival at day 28 without organ support, n (%)

54 (73.0%)

61 (67.8%)

0.47

58 (49.6%)

41 (38.7%)

0.102

SOFA h0

  Mean (SD)

9.5 (2.5)

9.6 (2.4)

0.851

10.6 (2.9)

10.6 (2.8)

0.987

  Median (IQR)

9 (8–11)

9 (8–11)

0.782

11 (8–12)

11 (8–12)

0.85

  n

75

92

 

122

108

 

SOFA h24

  Mean (SD)

9.4 (2.6)

9.8 (3)

0.273

11.9 (3.3)

11.6 (3.4)

0.526

  Median (IQR)

9 (7–11)

9 (8–12)

0.335

11 (10–14)

12 (9–14)

0.693

  n

75

89

 

112

104

 

SOFA h48

  Mean (SD)

7.8 (3.3)

9.6 (3.6)

0.001

10.8 (4.1)

10.8 (3.6)

0.962

  Median (IQR)

7 (6–10)

9 (7–12)

0.002

10 (8–14)

10 (9–14)

0.99

  n

71

82

 

93

80

 

SOFA h72

  Mean (SD)

6.6 (3.9)

8.4 (4.4)

0.008

9.9 (4.6)

9.2 (4.4)

0.374

  Median (IQR)

6 (4–9)

8 (5–11)

0.014

10 (6.8–13)

9 (6–13)

0.43

  n

65

82

 

88

71

 

SOFA d4

  Mean (SD)

6.3 (4.2)

6.9 (4.4)

0.436

8 (4.7)

6.9 (3.8)

0.136

  Median (IQR)

5 (3–8)

6 (4–10)

0.396

7 (4–11)

7 (4–9)

0.29

  n

53

67

 

69

57

 

SOFA d5

  Mean (SD)

5.9 (3.9)

6.1 (3.9)

0.815

8.3 (4.8)

6.4 (3.9)

0.024

  Median (IQR)

5.5 (3–8)

5 (3–8)

0.819

7 (5–11)

6 (4–9)

0.044

  n

44

63

 

62

51

 

SOFA d6

  Mean (SD)

5.5 (3.8)

5.8 (3.9)

0.704

7.8 (4.8)

6.4 (4)

0.108

  Median (IQR)

6 (3–7)

4 (3–9)

0.695

7 (4.5–10)

5.5 (3–9)

0.155

  n

37

55

 

59

44

 

SOFA d7

  Mean (SD)

5.4 (3.6)

5.8 (4.2)

0.726

8.1 (5)

4.9 (3.4)

0.001

  Median (IQR)

5 (3–7)

5 (3–8)

1

7 (4–10.2)

4 (2–7)

0.002

  n

29

47

 

48

34

 

PaO2 h0

  Mean (SD)

148.4 (95.1)

126.4 (63.8)

0.09

170 (105)

151.1 (82.9)

0.139

  Median (IQR)

116 (92–172)

113 (85–144)

0.289

139 (90–202)

130 (93–184)

0.295

  n

75

92

 

122

108

 

PaO2 h12

  Mean (SD)

97.1 (29.4)

265.4 (119)

< 0.0001

105.8 (44.9)

274.6 (136)

< 0.0001

  Median (IQR)

89 (75–117)

273 (172–367)

< 0.0001

96 (70–124)

277 (158–364)

< 0.0001

  n

69

86

 

109

103

 

PaO2 h24

  Mean (SD)

89.3 (27.7)

221.3 (115.8)

< 0.0001

101.0 (46.2)

229.8 (131.8)

< 0.0001

  Median (IQR)

82 (73–98.5)

211 (133–295)

< 0.0001

91 (77–109.2)

210.5 (119.8–322.8)

< 0.0001

  n

67

83

 

100

92

 

PaO2 h72

  Mean (SD)

88.9 (24.7)

96.5 (54.6)

0.306

88.6 (25.2)

92.4 (29.4)

0.431

  Median (IQR)

84 (71–101)

82 (74–107)

0.801

84.5 (71.8–96.8)

86 (74–98)

0.481

  n

55

69

 

72

61

 
  1. For mortality at day 28 and 90, respectively, an analysis in landmark with a log-rank test was used. For survival at day 28 without organ support and/or renal replacement therapy (RRT) a χ2 test was used. For the number of days without vasopressor therapy, without mechanical ventilation, and without RRT, respectively, a Student’s t test was used. ¥ = log-rank test; for mortality at day 28 in patients with a lactate > 2 mmol/L: χ2 test; d day, h hour